Literature DB >> 24221858

Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).

Gabriella Santangelo1, Paolo Barone, Giovanni Abbruzzese, Luigi Ferini-Strambi, Angelo Antonini.   

Abstract

Cognitive impairment (CI) is a frequent feature associated with both early and advanced stages of Parkinson's disease (PD). An evaluation of cognitive functions is relevant to identify those parkinsonians at risk of developing dementia. In the present study, the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) assessing fronto-subcortical and cortical cognitive functions in PD was validated in 387 parkinsonians and was used to test the empirical validity of the item 1.1 (cognitive impairment) of the Italian version of MDS-UPDRS as screening tool for CI in PD. PD-CRS was free from floor and ceiling effect. The mean PD-CRS score was 76.1 (mean cortical score, 24.5 ± 4.6; mean subcortical score, 51.5 ± 17.5). The internal consistency was satisfactory (α = 0.89); corrected item-total correlation was 0.570 (naming) to 0.696 (working memory). The correlation between PD-CRS and part I-IV of MDS-UPDRS was weak. The low agreement between classification of PD sample into patients with mild cognitive impairment (PD-MCI), dementia (PD-D) and normal cognition (PD-NC) according to scores of item 1.1 and classification according to cutoff scores of PD-CRS for PD-MCI, PD-D and PD-NC indicated a poor empirical validity of item 1.1 of MDS-UPDRS as cognitive screening tool for CI in PD (Κ = 0.114; weighted Κ = 0.17; SE of Κ = 0.038; 95 % confidence interval from 0.040 to 0.1895). The Italian version of PD-CRS is an easy, consistent and valid tool for assessment of the cognitive cortical and subcortical impairments in PD.

Entities:  

Mesh:

Year:  2013        PMID: 24221858     DOI: 10.1007/s10072-013-1538-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  15 in total

Review 1.  Assessing health status and quality-of-life instruments: attributes and review criteria.

Authors:  Neil Aaronson; Jordi Alonso; Audrey Burnam; Kathleen N Lohr; Donald L Patrick; Edward Perrin; Ruth E Stein
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

2.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

Review 3.  Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment.

Authors:  Per Svenningsson; Eric Westman; Clive Ballard; Dag Aarsland
Journal:  Lancet Neurol       Date:  2012-08       Impact factor: 44.182

4.  Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.

Authors:  Sabina Pappatà; G Santangelo; D Aarsland; C Vicidomini; K Longo; K Bronnick; M Amboni; R Erro; C Vitale; M G Caprio; M T Pellecchia; A Brunetti; G De Michele; M Salvatore; P Barone
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

Review 5.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

6.  Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Authors:  D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

Review 7.  Cognitive impairment in nondemented Parkinson's disease.

Authors:  Paolo Barone; Dag Aarsland; David Burn; Murat Emre; Jaime Kulisevsky; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-08-24       Impact factor: 10.338

8.  Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

Authors:  Javier Pagonabarraga; Jaime Kulisevsky; Gisela Llebaria; Carmen García-Sánchez; Berta Pascual-Sedano; Alexandre Gironell
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

9.  The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Authors:  Caroline H Williams-Gray; Jonathan R Evans; An Goris; Thomas Foltynie; Maria Ban; Trevor W Robbins; Carol Brayne; Bhaskar S Kolachana; Daniel R Weinberger; Stephen J Sawcer; Roger A Barker
Journal:  Brain       Date:  2009-10-07       Impact factor: 13.501

10.  [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].

Authors:  P Martínez-Martín; C Prieto-Jurczynska; B Frades-Payo
Journal:  Rev Neurol       Date:  2009 Oct 16-31       Impact factor: 0.870

View more
  8 in total

Review 1.  Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.

Authors:  Costanza Papagno; Luigi Trojano
Journal:  Neurol Sci       Date:  2017-10-17       Impact factor: 3.307

2.  The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.

Authors:  Gabriella Santangelo; Giovanna Lagravinese; Valeria Battini; Carlo Chiorri; Mattia Siciliano; Giovanni Abbruzzese; Carmine Vitale; Paolo Barone
Journal:  Neurol Sci       Date:  2017-02-21       Impact factor: 3.307

3.  The Italian version of the alternative form of Parkinson's Disease-Cognitive Rating Scale (PD-CRS/AF): normative values from 260 Italian healthy subjects.

Authors:  Alfonsina D'Iorio; Gianpaolo Maggi; Chiara Baiano; Gabriella Santangelo
Journal:  Neurol Sci       Date:  2022-01-27       Impact factor: 3.307

Review 4.  Psychometrics and diagnostics of Italian cognitive screening tests: a systematic review.

Authors:  Edoardo Nicolò Aiello; Sara Rimoldi; Nadia Bolognini; Ildebrando Appollonio; Giorgio Arcara
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

5.  What about the caregiver? A journey into Parkinson's disease following the burden tracks.

Authors:  Maria Rita Lo Monaco; Enrico Di Stasio; Maria Caterina Silveri; Anna Rita Bentivoglio; Diego Ricciardi; Marcella Solito; Martina Petracca; Domenico Fusco; Graziano Onder; Giovanni Landi; Giuseppe Zuccalà; Rosa Liperoti; Maria Camilla Cipriani; Caterina Brisi; Roberto Bernabei
Journal:  Aging Clin Exp Res       Date:  2020-06-02       Impact factor: 3.636

6.  Transcranial direct current stimulation enhances theory of mind in Parkinson's disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study.

Authors:  Mauro Adenzato; Rosa Manenti; Ivan Enrici; Elena Gobbi; Michela Brambilla; Antonella Alberici; Maria Sofia Cotelli; Alessandro Padovani; Barbara Borroni; Maria Cotelli
Journal:  Transl Neurodegener       Date:  2019-01-07       Impact factor: 8.014

7.  Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.

Authors:  Marcos Serrano-Dueñas; Maite Serrano; Diana Villena; David Granda
Journal:  Mov Disord Clin Pract       Date:  2016-03-01

8.  Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.

Authors:  Yuyan Tan; Weiguo Liu; Juanjuan Du; Miaomiao Hou; Cuiyu Yu; Yang Liu; Shishuang Cui; Lei Yan; Yizhou Lu; Hong Lv; Lijun Han; Xi Wang; Shengyu Zha; Xiaoguang Luo; Huidong Tang; Shengdi Chen
Journal:  Parkinsons Dis       Date:  2020-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.